Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_3
2
40%
Ph phase_2
2
40%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 32 (40.0%)
N/A1 (20.0%)

Trials by Status

terminated240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_2

Sodium Nitroprusside in Early Course Schizophrenia

NCT04986072
completedphase_3

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

NCT00617981
terminatedphase_2

Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

NCT01464593
completednot_applicable

Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain

NCT01168947
completedphase_3

N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery

NCT00188630

Clinical Trials (5)

Showing 5 of 5 trials
NCT04986072Phase 2

Sodium Nitroprusside in Early Course Schizophrenia

Terminated
NCT00617981Phase 3

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Completed
NCT01464593Phase 2

Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

Terminated
NCT01168947Not Applicable

Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain

Completed
NCT00188630Phase 3

N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5